Thaminda Ramanayake stands out for teaching the craft of biotech deal-making as much as practicing it, with a background that mixes molecular biology and immunology with a Wharton negotiation certificate and a psychology diploma from Moscow State University, later focusing his leadership on immune-system companies like CureVac and Anaveon after starting out as a published immunology researcher. He's also known for structuring complex, cross-border biotech deals and new company creation, and his focus on patient care goes back to volunteering at the Sri Lanka Cancer Hospital as a student, well before his career in venture and pharma began.